Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies.

Patricia Diaz-GalvanScott A PrzybelskiAlicia Algeciras-SchimnichDan J FigdoreTimothy G LesnickChristopher G SchwarzMatthew L SenjemJeffrey L GunterClifford R JackPaul H MinManoj K JainToji MiyagawaLeah K ForsbergJulie A FieldsRodolfo SavicaJonathan Graff-RadfordVijay K RamananDavid T JonesHugo BothaErik K St LouisDavid S KnopmanNeill R Graff-RadfordTanis J FermanRonald C PetersenVal J LoweBradley F BoeveKejal Kantarci

Published in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2024)

The range of AD co-pathology can be detected with plasma biomarkers in the DLB continuum, particularly with plasma p-tau-181 and GFAP.

Keyphrases

cognitive decline
cognitive impairment